CXCL8 and glioma: Based on our data showing a negative correlation between plasma IL-8 levels and overall survival, further studies are warranted to determine whether production of IL-8, which promotes progression of numerous malignancies, including high grade gliomas [35, 36], can be a surrogate measure of vaccine efficacy in future trials.